Jane Street Group, LLC Charles River Laboratories International, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 31,716 shares of CRL stock, worth $6.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,716

Previous 22,417 41.48%

Holding current value

$6.21 Million

Previous $4.63 Million 34.92%

% of portfolio

0.0%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$187.96 - $245.29 $1.75 Million - $2.28 Million	9,299 Added 41.48%	31,716 $6.25 Million
Q2 2024 Aug 14, 2024	BUY	$206.39 - $268.73 $1.09 Million - $1.42 Million	5,280 Added 30.81%	22,417 $4.63 Million
Q1 2024 May 15, 2024	BUY	$203.52 - $273.43 $445,505 - $598,538	2,189 Added 14.64%	17,137 $4.64 Million
Q4 2023 Feb 14, 2024	SELL	$164.52 - $238.84 $224,240 - $325,538	-1,363 Reduced 8.36%	14,948 $3.53 Million
Q3 2023 Nov 14, 2023	SELL	$194.44 - $217.61 $1.7 Million - $1.91 Million	-8,764 Reduced 34.95%	16,311 $3.2 Million
Q2 2023 Aug 14, 2023	BUY	$183.71 - $210.25 $544,149 - $622,760	2,962 Added 13.39%	25,075 $5.27 Million
Q1 2023 May 15, 2023	BUY	$191.89 - $259.92 $922,223 - $1.25 Million	4,806 Added 27.77%	22,113 $4.46 Million
Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $947,507 - $1.2 Million	4,807 Added 38.46%	17,307 $3.77 Million
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $2.28 Million - $3.13 Million	12,500 New	12,500 $2.46 Million
Q2 2022 Aug 16, 2022	SELL	$204.13 - $302.4 $1.71 Million - $2.53 Million	-8,376 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$255.51 - $362.11 $399,106 - $565,615	1,562 Added 22.92%	8,376 $2.38 Million
Q4 2021 Feb 15, 2022	BUY	$351.38 - $448.68 $226,288 - $288,949	644 Added 10.44%	6,814 $2.57 Million
Q3 2021 Nov 16, 2021	SELL	$372.64 - $458.3 $1.71 Million - $2.11 Million	-4,597 Reduced 42.7%	6,170 $2.55 Million
Q2 2021 Aug 16, 2021	BUY	$294.17 - $371.65 $1.42 Million - $1.79 Million	4,824 Added 81.17%	10,767 $3.98 Million
Q1 2021 May 18, 2021	BUY	$249.67 - $299.48 $50,183 - $60,195	201 Added 3.5%	5,943 $1.72 Million
Q4 2020 Feb 17, 2021	SELL	$222.0 - $252.62 $1.41 Million - $1.61 Million	-6,364 Reduced 52.57%	5,742 $1.44 Million
Q3 2020 Nov 17, 2020	BUY	$175.56 - $226.45 $1.89 Million - $2.44 Million	10,780 Added 812.97%	12,106 $2.74 Million
Q2 2020 Aug 17, 2020	BUY	$118.84 - $189.72 $157,581 - $251,568	1,326 New	1,326 $231,000
Q1 2020 May 15, 2020	SELL	$98.9 - $178.34 $358,809 - $647,017	-3,628 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$126.05 - $152.76 $306,805 - $371,817	-2,434 Reduced 40.15%	3,628 $554,000
Q3 2019 Nov 14, 2019	BUY	$125.07 - $143.67 $354,198 - $406,873	2,832 Added 87.68%	6,062 $802,000
Q2 2019 Aug 15, 2019	BUY	$123.4 - $148.55 $398,582 - $479,816	3,230 New	3,230 $458,000
Q1 2019 May 16, 2019	SELL	$104.82 - $146.73 $207,229 - $290,085	-1,977 Closed	0 $0
Q4 2018 Feb 15, 2019	SELL	$105.09 - $137.23 $1.19 Million - $1.56 Million	-11,332 Reduced 85.15%	1,977 $224,000
Q3 2018 Nov 14, 2018	BUY	$112.11 - $134.54 $899,682 - $1.08 Million	8,025 Added 151.87%	13,309 $1.79 Million
Q2 2018 Aug 15, 2018	BUY	$102.37 - $117.25 $540,923 - $619,549	5,284 New	5,284 $593,000
Q4 2017 Feb 15, 2018	SELL	$100.43 - $118.09 $242,638 - $285,305	-2,416 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$96.72 - $109.26 $233,675 - $263,972	2,416	2,416 $261,000

Others Institutions Holding CRL

# of Institutions

696

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.96B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Charles River Laboratories International, Inc. Transaction History